Post job

KSQ Therapeutics's revenue is $2.6 million.

What is KSQ Therapeutics's revenue?

KSQ Therapeutics's annual revenue is $2.6M. Zippia's data science team found the following key financial metrics about KSQ Therapeutics after extensive research and analysis.
  • KSQ Therapeutics has 60 employees, and the revenue per employee ratio is $43,333.
  • KSQ Therapeutics peak revenue was $2.6M in 2024.

On this page

Peak revenue
$2.6M (2025)
Company peak revenue
Revenue / employee
$43,333
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$2.6M (2025)
Company peak revenue
Revenue / employee
$43,333
Company revenue / employee

KSQ Therapeutics financing

KSQ Therapeutics received early financing of $76.0M on 2017-10-02.

SeriesRound sizeDate
Series B$76M10/2017
Series C$80M09/2018

KSQ Therapeutics investors

InvestorsSecurity type
Polaris PartnersSeries B
ARCH Venture PartnersSeries B
ALEXANDRIA REAL ESTATE EQUITIES, INC.Series B
Flagship Pioneering IncSeries B
Polaris PartnersSeries C
Lilly Asia VenturesSeries C
InvusSeries C
Baillie GiffordSeries C
ARCH Venture PartnersSeries C
ALEXANDRIA REAL ESTATE EQUITIES, INC.Series C
Flagship Pioneering IncSeries C
Cowen Healthcare InvestmentsSeries C

KSQ Therapeutics competitors

KSQ Therapeutics's top competitor, Blueprint Medicines, earned an annual revenue of $508.8M.

KSQ Therapeutics's smallest competitor is CRISPR Therapeutics with revenue of $37.3M last year.

KSQ Therapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of KSQ Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about KSQ Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at KSQ Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by KSQ Therapeutics. The data presented on this page does not represent the view of KSQ Therapeutics and its employees or that of Zippia.

KSQ Therapeutics may also be known as or be related to KSQ Therapeutics, KSQ Therapeutics Inc, KSQ Therapeutics, Inc. and Ksq Therapeutics, Inc.